Pub Date : 2026-01-01Epub Date: 2025-09-29DOI: 10.1177/0272989X251377458
Nancy L Schoenborn, Sarah E Gollust, Rebekah H Nagler, Mara A Schonberg, Cynthia M Boyd, Qian-Li Xue, Yaldah M Nader, Craig E Pollack
BackgroundMessaging strategies hold promise to reduce breast cancer overscreening. However, it is not known whether they may have differential effects among medical maximizers who prefer to take action about their health versus medical minimizers who prefer to wait and see.MethodsIn a randomized controlled survey experiment that included 2 sequential surveys with 3,041 women aged 65+ y from a US population-based online panel, we randomized participants to 1) no messages, 2) single exposure to a screening cessation message, or 3) 2 exposures over time to the screening cessation message. We assessed support for stopping screening in a hypothetical patient and intention to stop screening oneself on 7-point scales, where higher values indicated stronger support and intentions to stop screening. We conducted stratified analyses by medical-maximizing preference and moderation analysis.ResultsOf the women, 40.7% (n = 1,238) were medical maximizers; they had lower support and intention for screening cessation in all groups compared with the medical minimizers. Two message exposures increased support for screening cessation among medical maximizers, with a mean score of 3.68 (95% confidence interval [CI] 3.51-3.85) compared with no message (mean score 2.20, 95% CI 2.00-2.39, P < 0.001). A similar pattern was seen for screening intention. Linear regression models showed no differential messaging effect by medical-maximizing preference.ConclusionsMedical maximizers, although less likely to support screening cessation, were nonetheless responsive to messaging strategies designed to reduce breast cancer overscreening.HighlightsIt is not known if a message on rationales for stopping breast cancer screening would have differential effects among medical maximizers who prefer to take action when it comes to their health versus medical minimizers who prefer to wait and see.In a 2-wave randomized controlled survey experiment with 3,041 older women, we found that medical maximizers, although less likely to support screening cessation compared with medical minimizers, were nonetheless responsive to the messaging intervention, and the magnitude of the intervention effect was similar between maximizers and minimizers.Medical maximizers reported higher levels of worry and annoyance after reading the message compared with the minimizers, but the absolute levels of worry and annoyance were low.Our findings suggest that messaging can be a useful tool for reducing overscreening even in a highly reluctant population.
短信策略有望减少乳腺癌的过度筛查。然而,目前尚不清楚它们是否会在医疗最大化者和医疗最小化者之间产生不同的影响,前者更愿意为自己的健康采取行动,后者更愿意观望。方法在一项随机对照调查实验中,我们对3041名65岁以上的女性进行了2次连续调查,这些女性来自一个基于美国人群的在线小组,我们将参与者随机分为3组:1)没有信息,2)单一暴露于筛查性戒烟信息,或3)2次暴露于筛查性戒烟信息。我们以7分制评估了对假设患者停止筛查的支持度和自己停止筛查的意愿,其中较高的值表示更强的支持度和停止筛查的意愿。我们通过医学最大化偏好和适度分析进行分层分析。结果40.7% (n = 1238)的女性是医学最大化者;与医学最小化者相比,他们在所有组中对筛查戒烟的支持度和意愿都较低。两种信息暴露增加了对药物最大化者筛查戒烟的支持,平均得分为3.68(95%可信区间[CI] 3.51-3.85),而无信息暴露者(平均得分2.20,95% CI 2.00-2.39, P < 0.001)。筛选意向也出现了类似的模式。线性回归模型显示,医疗最大化偏好没有差异信息效应。结论:医学最大化者虽然不太可能支持停止筛查,但仍然对旨在减少乳腺癌过度筛查的信息策略有反应。目前尚不清楚关于停止乳腺癌筛查的理由的信息是否会在医疗最大化者和医疗最小化者之间产生不同的影响,前者在涉及到自己的健康时更愿意采取行动,后者更愿意观望。在一项对3041名老年妇女进行的两波随机对照调查实验中,我们发现,尽管与医疗最小化者相比,医疗最大化者不太可能支持筛查停止,但仍然对信息干预有反应,并且最大化者和最小化者之间的干预效果相似。与最小化者相比,医学最大化者在阅读信息后报告的担忧和烦恼程度更高,但绝对担忧和烦恼程度较低。我们的研究结果表明,即使是在极不情愿的人群中,短信也可以成为减少过度筛查的有用工具。
{"title":"Does Messaging for Reducing Breast Cancer Overscreening in Older Women Have Differential Responses among Medical Minimizers and Maximizers?","authors":"Nancy L Schoenborn, Sarah E Gollust, Rebekah H Nagler, Mara A Schonberg, Cynthia M Boyd, Qian-Li Xue, Yaldah M Nader, Craig E Pollack","doi":"10.1177/0272989X251377458","DOIUrl":"10.1177/0272989X251377458","url":null,"abstract":"<p><p>BackgroundMessaging strategies hold promise to reduce breast cancer overscreening. However, it is not known whether they may have differential effects among medical maximizers who prefer to take action about their health versus medical minimizers who prefer to wait and see.MethodsIn a randomized controlled survey experiment that included 2 sequential surveys with 3,041 women aged 65+ y from a US population-based online panel, we randomized participants to 1) no messages, 2) single exposure to a screening cessation message, or 3) 2 exposures over time to the screening cessation message. We assessed support for stopping screening in a hypothetical patient and intention to stop screening oneself on 7-point scales, where higher values indicated stronger support and intentions to stop screening. We conducted stratified analyses by medical-maximizing preference and moderation analysis.ResultsOf the women, 40.7% (<i>n</i> = 1,238) were medical maximizers; they had lower support and intention for screening cessation in all groups compared with the medical minimizers. Two message exposures increased support for screening cessation among medical maximizers, with a mean score of 3.68 (95% confidence interval [CI] 3.51-3.85) compared with no message (mean score 2.20, 95% CI 2.00-2.39, <i>P</i> < 0.001). A similar pattern was seen for screening intention. Linear regression models showed no differential messaging effect by medical-maximizing preference.ConclusionsMedical maximizers, although less likely to support screening cessation, were nonetheless responsive to messaging strategies designed to reduce breast cancer overscreening.HighlightsIt is not known if a message on rationales for stopping breast cancer screening would have differential effects among medical maximizers who prefer to take action when it comes to their health versus medical minimizers who prefer to wait and see.In a 2-wave randomized controlled survey experiment with 3,041 older women, we found that medical maximizers, although less likely to support screening cessation compared with medical minimizers, were nonetheless responsive to the messaging intervention, and the magnitude of the intervention effect was similar between maximizers and minimizers.Medical maximizers reported higher levels of worry and annoyance after reading the message compared with the minimizers, but the absolute levels of worry and annoyance were low.Our findings suggest that messaging can be a useful tool for reducing overscreening even in a highly reluctant population.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"26-34"},"PeriodicalIF":3.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12679435/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145187329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-11-08DOI: 10.1177/0272989X251388046
Si Ning Germaine Tan, Charles Muiruri, Juan Marcos Gonzalez Sepulveda
BackgroundMedication adherence is a critical factor in hypertension management, which remains a challenge for public health systems.MethodsGraded-pair questions were used to quantify the perception of how much nonadherence to antihypertensives increases the risk of serious cardiovascular events. A discrete-choice experiment was used to quantify the relative importance of medication outcomes (e.g., reduction in cardiovascular event risk and medication side effects). Rating questions were used to assess perspectives of the effect of treatment nonadherence on treatment side effects. Results were combined to assess how preferences and outcome expectations influence adherence.ResultsPatients perceived treatment adherence as the most significant contributor to cardiovascular event risk. A reduction in cardiovascular risk was the most significant consideration when choosing medication. Missing consecutive (v. alternate) doses was associated with greater perceived cardiovascular risk and fewer side effects. The differences between complete adherence and any level of nonadherence were significantly larger for side effects than for changes in the risk of cardiovascular events, suggesting that side effects are perceived to be more sensitive to nonadherence than treatment efficacy.LimitationsOur study relied on hypothetical scenarios, which may not fully capture real-world decision making. While our findings shed light on the relationship between adherence patterns and treatment perceptions, it is essential to recognize the complexity of adherence behavior.ConclusionsPatients believe that they can manage medication side effects by skipping doses without compromising the efficacy to the same degree and that they can offset compromises in efficacy by avoiding missing consecutive doses for prolonged periods.ImplicationsHealth care providers should understand the importance of patient education and counseling to address misconceptions and promote realistic expectations regarding treatment efficacy and the consequences of nonadherence.HighlightsThe average patient believes that they can manage medication side effects by skipping doses without compromising the efficacy to the same degree.There is a belief that patients can offset some of the impact of nonadherence on their cardiovascular event risk, particularly if they avoid missing consecutive doses for prolonged periods of time.This highlights the importance of patient education and counseling to address misconceptions and promote realistic expectations regarding treatment efficacy and the consequences of nonadherence.
{"title":"Do Patient Preferences and Treatment Beliefs Explain Patterns of Antihypertensive Medication Nonadherence? A Discrete Choice Experiment.","authors":"Si Ning Germaine Tan, Charles Muiruri, Juan Marcos Gonzalez Sepulveda","doi":"10.1177/0272989X251388046","DOIUrl":"10.1177/0272989X251388046","url":null,"abstract":"<p><p>BackgroundMedication adherence is a critical factor in hypertension management, which remains a challenge for public health systems.MethodsGraded-pair questions were used to quantify the perception of how much nonadherence to antihypertensives increases the risk of serious cardiovascular events. A discrete-choice experiment was used to quantify the relative importance of medication outcomes (e.g., reduction in cardiovascular event risk and medication side effects). Rating questions were used to assess perspectives of the effect of treatment nonadherence on treatment side effects. Results were combined to assess how preferences and outcome expectations influence adherence.ResultsPatients perceived treatment adherence as the most significant contributor to cardiovascular event risk. A reduction in cardiovascular risk was the most significant consideration when choosing medication. Missing consecutive (v. alternate) doses was associated with greater perceived cardiovascular risk and fewer side effects. The differences between complete adherence and any level of nonadherence were significantly larger for side effects than for changes in the risk of cardiovascular events, suggesting that side effects are perceived to be more sensitive to nonadherence than treatment efficacy.LimitationsOur study relied on hypothetical scenarios, which may not fully capture real-world decision making. While our findings shed light on the relationship between adherence patterns and treatment perceptions, it is essential to recognize the complexity of adherence behavior.ConclusionsPatients believe that they can manage medication side effects by skipping doses without compromising the efficacy to the same degree and that they can offset compromises in efficacy by avoiding missing consecutive doses for prolonged periods.ImplicationsHealth care providers should understand the importance of patient education and counseling to address misconceptions and promote realistic expectations regarding treatment efficacy and the consequences of nonadherence.HighlightsThe average patient believes that they can manage medication side effects by skipping doses without compromising the efficacy to the same degree.There is a belief that patients can offset some of the impact of nonadherence on their cardiovascular event risk, particularly if they avoid missing consecutive doses for prolonged periods of time.This highlights the importance of patient education and counseling to address misconceptions and promote realistic expectations regarding treatment efficacy and the consequences of nonadherence.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"47-59"},"PeriodicalIF":3.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145472404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-09-29DOI: 10.1177/0272989X251368886
Kathleen F Kerr, Megan M Eguchi, Hannah Shucard, Trafton Drew, Donald L Weaver, Joann G Elmore, Tad T Brunyé
ObjectiveTo study the effects of exposure to a prior diagnosis (PD) on second opinions in breast pathology.Materials and MethodsPathologists interpreted digital breast biopsy cases in 2 phases separated by a washout. Phase 2 interpretations were randomly assigned to PD or no PD. When presented, PD was always more or less severe than a participant's phase 1 diagnosis. Viewing behaviors, including zoom level, were recorded during all interpretations. Twenty pathologists yielded 556 interpretations of 32 different cases.ResultsPathologists were 71% more likely to give a less severe diagnosis when exposed to a less severe PD than with no PD (RR 1.71, 95% CI 1.33-2.20, P < 0.001). In comparison, when exposed to a more severe PD than with no PD, pathologists were 27% more likely to give a more severe diagnosis, but the effect was not significant (RR 1.27, 95% CI 0.87-1.86, P = 0.223). Compared with no PD, viewing behavior shifted toward more focus on critical image regions with exposure to a less severe PD and toward higher zoom levels with exposure to a more severe PD.DiscussionResults indicate anchoring and confirmation biases from PD exposure, such that second opinions after PD exposure are not independent assessments. Viewing behaviors illustrated how PD alters the interpretive process, including increased zooming when exposed to a more severe PD. Results have implications for best practices for computer-aided diagnosis tools.ImplicationsWhen giving a second opinion, exposure to a PD can sway diagnostic classifications and alter interpretive behavior, highlighting a need for protocols that encourage independent assessments.HighlightsIn pathology diagnosis, second opinions are systematically influenced by prior diagnostic information.Less severe prior diagnoses shift pathologists' visual attention toward clinically critical regions of a pathology image, whereas more severe prior diagnoses tend to elicit increased magnification during case interpretation.Specific viewing behaviors partially mediate the effect of prior diagnoses on second opinion diagnoses.When prior diagnoses are disclosed to pathologists, anchoring and confirmation biases undermine the independence of second opinion decisions.
目的探讨事先诊断(PD)对乳腺病理第二意见的影响。材料与方法病理学家将数字乳腺活检病例分为两个阶段进行解释。第2期口译随机分为PD组和非PD组。当出现时,PD总是比参与者的第一阶段诊断更严重或更严重。在所有解译过程中记录观看行为,包括缩放级别。20位病理学家对32个不同的病例做出了556种解释。结果当暴露于较轻的PD时,病理学家给出较轻诊断的可能性比暴露于无PD时高71% (RR 1.71, 95% CI 1.33-2.20, P < 0.001)。相比之下,当暴露于更严重的PD时,病理学家给出更严重诊断的可能性比没有PD时高27%,但效果不显著(RR 1.27, 95% CI 0.87-1.86, P = 0.223)。与无PD组相比,暴露于轻度PD组时,观看行为更倾向于关注关键图像区域,暴露于重度PD组时,观看行为更倾向于提高变焦水平。讨论结果表明PD暴露的锚定和确认偏差,因此PD暴露后的第二意见不是独立的评估。观察行为说明了PD如何改变解释过程,包括当暴露于更严重的PD时增加缩放。结果对计算机辅助诊断工具的最佳实践具有启示意义。当给出第二意见时,暴露于PD可能会影响诊断分类并改变解释行为,强调需要鼓励独立评估的协议。在病理诊断中,第二意见系统地受到先前诊断信息的影响。较不严重的先前诊断将病理学家的视觉注意力转移到病理图像的临床关键区域,而较严重的先前诊断往往会在病例解释过程中引起放大。特定的观看行为在一定程度上介导了先前诊断对第二意见诊断的影响。当先前的诊断向病理学家披露时,锚定和确认偏见破坏了第二意见决定的独立性。
{"title":"Effects of Prior Diagnosis on Second Opinions and Pathologist Viewing Behaviors: Results from a Randomized Trial in Breast Pathology.","authors":"Kathleen F Kerr, Megan M Eguchi, Hannah Shucard, Trafton Drew, Donald L Weaver, Joann G Elmore, Tad T Brunyé","doi":"10.1177/0272989X251368886","DOIUrl":"10.1177/0272989X251368886","url":null,"abstract":"<p><p>ObjectiveTo study the effects of exposure to a prior diagnosis (PD) on second opinions in breast pathology.Materials and MethodsPathologists interpreted digital breast biopsy cases in 2 phases separated by a washout. Phase 2 interpretations were randomly assigned to PD or no PD. When presented, PD was always more or less severe than a participant's phase 1 diagnosis. Viewing behaviors, including zoom level, were recorded during all interpretations. Twenty pathologists yielded 556 interpretations of 32 different cases.ResultsPathologists were 71% more likely to give a less severe diagnosis when exposed to a less severe PD than with no PD (RR 1.71, 95% CI 1.33-2.20, <i>P</i> < 0.001). In comparison, when exposed to a more severe PD than with no PD, pathologists were 27% more likely to give a more severe diagnosis, but the effect was not significant (RR 1.27, 95% CI 0.87-1.86, <i>P</i> = 0.223). Compared with no PD, viewing behavior shifted toward more focus on critical image regions with exposure to a less severe PD and toward higher zoom levels with exposure to a more severe PD.DiscussionResults indicate anchoring and confirmation biases from PD exposure, such that second opinions after PD exposure are not independent assessments. Viewing behaviors illustrated how PD alters the interpretive process, including increased zooming when exposed to a more severe PD. Results have implications for best practices for computer-aided diagnosis tools.ImplicationsWhen giving a second opinion, exposure to a PD can sway diagnostic classifications and alter interpretive behavior, highlighting a need for protocols that encourage independent assessments.HighlightsIn pathology diagnosis, second opinions are systematically influenced by prior diagnostic information.Less severe prior diagnoses shift pathologists' visual attention toward clinically critical regions of a pathology image, whereas more severe prior diagnoses tend to elicit increased magnification during case interpretation.Specific viewing behaviors partially mediate the effect of prior diagnoses on second opinion diagnoses.When prior diagnoses are disclosed to pathologists, anchoring and confirmation biases undermine the independence of second opinion decisions.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"76-87"},"PeriodicalIF":3.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12731604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145187374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-09-15DOI: 10.1177/0272989X251368866
Lena Fischer, Rahel Wollny, Leon V Schewe, Fülöp Scheibler, Torsten Karge, Thomas Langer, Corinna Schaefer, Ivan D Florez, Andrew Hutchinson, Sheyu Li, Marta Maes-Carballo, Zachary Munn, Lilisbeth Perestelo-Perez, Livia Puljak, Anne Stiggelbout, Dawid Pieper
Background. Awareness of shared decision making (SDM) is growing, but its integration into clinical practice guidelines (CPGs) remains challenging. We sought expert insights to identify strategies for more successfully integrating SDM and decision support tools into CPGs. Specifically, our objectives were to determine 1) how to identify CPG recommendations where SDM is most relevant and 2) what factors in CPG development hinder or facilitate the consideration of SDM and the development of decision support tools. Methods. We conducted semi-structured interviews with experts on CPGs and SDM. We analyzed the data using Mayring's qualitative content analysis. Results. The 16 interviewed participants proposed several determinants of and strategies for identifying SDM-relevant recommendations. The most frequently mentioned determinant was "multiple options with benefits and harms where choices depend on individual preferences." The most frequently mentioned strategy was prioritization, similar to the CPG scoping phase. Participants highlighted the role of patient partners in facilitating the consideration of SDM in CPG development but noted that a supportive culture toward both patient and public involvement and SDM is needed. The absence of standardized methods and inadequate resources hinder the consideration of SDM and the combined development of CPGs and decision support tools. The current format of CPGs was deemed overwhelming, while the inclusion of choice awareness in CPG recommendations could facilitate SDM. Conclusions. The identified strategies provide a starting point for CPG organizations to explore ways for integrating SDM and decision support tools into CPGs while considering context-specific barriers and facilitators. Implications. Further research is needed to assess the usefulness and feasibility of the proposed strategies. New policies and stronger collaboration between CPG and SDM communities appear to be needed to address identified barriers.HighlightsWe explored expert knowledge and experience on how to successfully integrate shared decision making (SDM) and decision support tools into clinical practice guidelines (CPGs).A combined development of CPGs and decision support tools was deemed essential; however, development processes often remain separate, with the CPG development group unaware of the decision support tool development group, and vice versa.In addition to stating choice awareness in CPGs, participants highlighted the critical role of patient partners in considering SDM in CPG development, but resource issues and a culture that neglects patient involvement and SDM remain.For CPG development groups to consider SDM and for health care professionals to practice it, things need to be as easy as possible.
{"title":"Integrating Shared Decision Making and Decision Support Tools into Clinical Practice Guidelines: What Does It Take? A Qualitative Study.","authors":"Lena Fischer, Rahel Wollny, Leon V Schewe, Fülöp Scheibler, Torsten Karge, Thomas Langer, Corinna Schaefer, Ivan D Florez, Andrew Hutchinson, Sheyu Li, Marta Maes-Carballo, Zachary Munn, Lilisbeth Perestelo-Perez, Livia Puljak, Anne Stiggelbout, Dawid Pieper","doi":"10.1177/0272989X251368866","DOIUrl":"10.1177/0272989X251368866","url":null,"abstract":"<p><p><b>Background.</b> Awareness of shared decision making (SDM) is growing, but its integration into clinical practice guidelines (CPGs) remains challenging. We sought expert insights to identify strategies for more successfully integrating SDM and decision support tools into CPGs. Specifically, our objectives were to determine 1) how to identify CPG recommendations where SDM is most relevant and 2) what factors in CPG development hinder or facilitate the consideration of SDM and the development of decision support tools. <b>Methods</b>. We conducted semi-structured interviews with experts on CPGs and SDM. We analyzed the data using Mayring's qualitative content analysis. <b>Results.</b> The 16 interviewed participants proposed several determinants of and strategies for identifying SDM-relevant recommendations. The most frequently mentioned determinant was \"multiple options with benefits and harms where choices depend on individual preferences.\" The most frequently mentioned strategy was prioritization, similar to the CPG scoping phase. Participants highlighted the role of patient partners in facilitating the consideration of SDM in CPG development but noted that a supportive culture toward both patient and public involvement and SDM is needed. The absence of standardized methods and inadequate resources hinder the consideration of SDM and the combined development of CPGs and decision support tools. The current format of CPGs was deemed overwhelming, while the inclusion of choice awareness in CPG recommendations could facilitate SDM. <b>Conclusions.</b> The identified strategies provide a starting point for CPG organizations to explore ways for integrating SDM and decision support tools into CPGs while considering context-specific barriers and facilitators. <b>Implications.</b> Further research is needed to assess the usefulness and feasibility of the proposed strategies. New policies and stronger collaboration between CPG and SDM communities appear to be needed to address identified barriers.HighlightsWe explored expert knowledge and experience on how to successfully integrate shared decision making (SDM) and decision support tools into clinical practice guidelines (CPGs).A combined development of CPGs and decision support tools was deemed essential; however, development processes often remain separate, with the CPG development group unaware of the decision support tool development group, and vice versa.In addition to stating choice awareness in CPGs, participants highlighted the critical role of patient partners in considering SDM in CPG development, but resource issues and a culture that neglects patient involvement and SDM remain.For CPG development groups to consider SDM and for health care professionals to practice it, things need to be as easy as possible.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"60-75"},"PeriodicalIF":3.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145071083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-26DOI: 10.1177/0272989X251406639
Sara Garber, Yarema Okhrin
BackgroundWhile machine learning (ML) models are increasingly used to predict outcomes in health care, their practical effect on health care operations, such as bed capacity management, remains underexplored. There is a variety of traditionally used evaluation metrics to analyze ML models; however, decision makers in health care settings require a deeper understanding of their implications for resource management. Traditional performance measures often fail to provide this practical insight.MethodsIn this work, we conduct a simulation study to evaluate the impact of ML-driven length-of-stay (LOS) predictions on intensive care unit (ICU) bed capacity management. Two classification models differing in terms of explainability and interpretability, logistic regression (LR) and extreme gradient boosting (XGB), are applied to predict ICU-LOS. We use the HiRID dataset containing high-frequency data of more than 33,000 patients. The predictions of the ML models are integrated into a simulation framework that replicates real-world ICU bed management, allowing for the assessment of the practical implications of using these algorithms in a clinical setting.ResultsThe application of both classification models results in improved capacity control regarding the key performance indicators in the simulation study, with XGB outperforming LR. While LR leads to slight overoccupancy in the ICU, slight underoccupancy can be observed when XGB is applied.ConclusionOur study bridges the gap between predictive accuracy and practical application by emphasizing the importance of evaluating ML models within the context of ICU capacity management. The simulation-based approach offers a more relevant assessment for health care practitioners, providing actionable insights that go beyond classical performance measures and directly address the needs of decision makers in clinical practice.HighlightsWe apply multiple classification models for ICU-LOS prediction using time-series data. This approach enables an update of the initial prediction resulting in the possibility of efficiently managing intensive care capacities.We present a simulation-based approach to evaluate ML algorithms and their impact on bed capacity management in real-world clinical settings.Our work provides in-depth insights into the impact of using ML techniques as decision support systems in the ICU and can lead to increased acceptance in practice.
{"title":"Machine Learning for Intensive Care Unit Length-of-Stay Prediction: A Simulation-Based Approach to Bed Capacity Management.","authors":"Sara Garber, Yarema Okhrin","doi":"10.1177/0272989X251406639","DOIUrl":"https://doi.org/10.1177/0272989X251406639","url":null,"abstract":"<p><p>BackgroundWhile machine learning (ML) models are increasingly used to predict outcomes in health care, their practical effect on health care operations, such as bed capacity management, remains underexplored. There is a variety of traditionally used evaluation metrics to analyze ML models; however, decision makers in health care settings require a deeper understanding of their implications for resource management. Traditional performance measures often fail to provide this practical insight.MethodsIn this work, we conduct a simulation study to evaluate the impact of ML-driven length-of-stay (LOS) predictions on intensive care unit (ICU) bed capacity management. Two classification models differing in terms of explainability and interpretability, logistic regression (LR) and extreme gradient boosting (XGB), are applied to predict ICU-LOS. We use the HiRID dataset containing high-frequency data of more than 33,000 patients. The predictions of the ML models are integrated into a simulation framework that replicates real-world ICU bed management, allowing for the assessment of the practical implications of using these algorithms in a clinical setting.ResultsThe application of both classification models results in improved capacity control regarding the key performance indicators in the simulation study, with XGB outperforming LR. While LR leads to slight overoccupancy in the ICU, slight underoccupancy can be observed when XGB is applied.ConclusionOur study bridges the gap between predictive accuracy and practical application by emphasizing the importance of evaluating ML models within the context of ICU capacity management. The simulation-based approach offers a more relevant assessment for health care practitioners, providing actionable insights that go beyond classical performance measures and directly address the needs of decision makers in clinical practice.HighlightsWe apply multiple classification models for ICU-LOS prediction using time-series data. This approach enables an update of the initial prediction resulting in the possibility of efficiently managing intensive care capacities.We present a simulation-based approach to evaluate ML algorithms and their impact on bed capacity management in real-world clinical settings.Our work provides in-depth insights into the impact of using ML techniques as decision support systems in the ICU and can lead to increased acceptance in practice.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"272989X251406639"},"PeriodicalIF":3.1,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145844492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-24DOI: 10.1177/0272989X251405892
Karen Sepucha, Ha Vo, Felisha Marques, Kathrene D Valentine, Ayesha Abdeen, Hany Bedair, Antonia F Chen, Jesse Eisler, David Freccero, Prakash Jayakumar, Emily Kropfl, Kathleen Paul, Benjamin Ricciardi, Daniel Vigil, Richard Wexler, Theresa Williamson, Adolph Yates, Thomas Cha
BackgroundDecision aids (DAs) are evidence-based tools to improve patient-centered care, but their use in routine care is limited. The purpose of this project was to work with orthopedic practices to deliver DAs.MethodsEligible sites needed to identify an administrative and clinical champion and have access to DAs for treatment of hip, knee, and/or spine conditions. The implementation strategies included an Orthopaedic Learning Collaborative (OLC), external facilitation, and audit and feedback. The project was conducted over 15 mo with 5 OLC sessions, individual monthly meetings, and monthly data reports. Clinicians and staff completed a baseline survey prior to the start of the project. Sites provided details on their DA workflow and number of DAs delivered. We calculated adoption (the number of specialists who used DAs) and estimated reach (percentage of eligible patients who received DAs). We calculated descriptive statistics and explored predictors of reach.ResultsTwelve participating sites had an average annual orthopedic surgical volume of 550, half were academic medical centers, and some (4/13, 30.7%) had prior experience with orthopedic DAs. Adoption was 76% (60/79 physicians). Sites distributed 9,626 DAs and reached 44% of eligible patients (range 7%-100%). Sites that indicated at baseline that DA delivery was a high priority for staff had higher reach (60% reach for high v. 47% for moderate v. 9% for low priority, P = 0.21). Sites with no prior experience with DAs had higher reach than those with prior experience did (60% v. 38%, P = 0.26, d = 0.71).ConclusionsParticipating sites were able to implement workflows that reached about half of eligible patients. Establishing DA delivery as a priority for staff at the outset appears important for reach, while prior experience does not.HighlightsThe 12 sites were able to reach, on average, 44% of eligible patients with decision aids in routine care demonstrating feasibility of distribution.The study and associated implementation toolkit provide concrete examples of workflows for orthopedic practices interested in incorporating decision aids into routine care.A bundle of implementation strategies, including a learning collaborative, external facilitation, and audit and feedback, helped most sites meet targets for decision aid implementation.
决策辅助(DAs)是一种以证据为基础的工具,可以改善以患者为中心的护理,但其在常规护理中的应用有限。该项目的目的是与骨科实践合作,提供DAs。方法符合条件的地点需要确定行政和临床冠军,并且可以获得DAs治疗髋关节,膝关节和/或脊柱疾病。实施策略包括骨科学习协作(OLC)、外部促进、审计和反馈。该项目进行了15个多月,包括5次OLC会议、个别月度会议和月度数据报告。临床医生和工作人员在项目开始前完成了基线调查。网站详细介绍了他们的DA工作流程和交付的DA数量。我们计算了采用率(使用DAs的专家数量)和估计覆盖率(接受DAs的合格患者的百分比)。我们计算了描述性统计数据,并探索了到达的预测因素。结果12个参与调查的医院平均年骨科手术量为550例,其中一半是学术性医疗中心,其中4/13(30.7%)有骨科DAs经验。采用率为76%(60/79)。站点分发了9626个DAs,达到44%的符合条件的患者(范围7%-100%)。在基线时表明,DA交付对员工来说是高优先级的站点有更高的覆盖率(60%为高优先级,47%为中等优先级,9%为低优先级,P = 0.21)。没有DAs经验的站点的覆盖率高于有DAs经验的站点(60% vs 38%, P = 0.26, d = 0.71)。结论参与站点能够实施的工作流程覆盖了约一半的符合条件的患者。从一开始就把提供发展援助作为工作人员的优先事项,似乎对实现目标很重要,而以前的经验则不然。12个站点平均有44%的符合条件的患者在日常护理中使用决策辅助工具,证明了分配的可行性。该研究和相关的实施工具包为骨科实践中有兴趣将决策辅助纳入日常护理的工作流程提供了具体的例子。一系列实施策略,包括学习协作、外部促进、审计和反馈,帮助大多数站点实现了决策辅助实施的目标。
{"title":"Patient Decision Aids into Routine Orthopedic Care: Results from an Implementation Study at 12 Sites.","authors":"Karen Sepucha, Ha Vo, Felisha Marques, Kathrene D Valentine, Ayesha Abdeen, Hany Bedair, Antonia F Chen, Jesse Eisler, David Freccero, Prakash Jayakumar, Emily Kropfl, Kathleen Paul, Benjamin Ricciardi, Daniel Vigil, Richard Wexler, Theresa Williamson, Adolph Yates, Thomas Cha","doi":"10.1177/0272989X251405892","DOIUrl":"https://doi.org/10.1177/0272989X251405892","url":null,"abstract":"<p><p>BackgroundDecision aids (DAs) are evidence-based tools to improve patient-centered care, but their use in routine care is limited. The purpose of this project was to work with orthopedic practices to deliver DAs.MethodsEligible sites needed to identify an administrative and clinical champion and have access to DAs for treatment of hip, knee, and/or spine conditions. The implementation strategies included an Orthopaedic Learning Collaborative (OLC), external facilitation, and audit and feedback. The project was conducted over 15 mo with 5 OLC sessions, individual monthly meetings, and monthly data reports. Clinicians and staff completed a baseline survey prior to the start of the project. Sites provided details on their DA workflow and number of DAs delivered. We calculated adoption (the number of specialists who used DAs) and estimated reach (percentage of eligible patients who received DAs). We calculated descriptive statistics and explored predictors of reach.ResultsTwelve participating sites had an average annual orthopedic surgical volume of 550, half were academic medical centers, and some (4/13, 30.7%) had prior experience with orthopedic DAs. Adoption was 76% (60/79 physicians). Sites distributed 9,626 DAs and reached 44% of eligible patients (range 7%-100%). Sites that indicated at baseline that DA delivery was a high priority for staff had higher reach (60% reach for high v. 47% for moderate v. 9% for low priority, <i>P</i> = 0.21). Sites with no prior experience with DAs had higher reach than those with prior experience did (60% v. 38%, <i>P</i> = 0.26, <i>d</i> = 0.71).ConclusionsParticipating sites were able to implement workflows that reached about half of eligible patients. Establishing DA delivery as a priority for staff at the outset appears important for reach, while prior experience does not.HighlightsThe 12 sites were able to reach, on average, 44% of eligible patients with decision aids in routine care demonstrating feasibility of distribution.The study and associated implementation toolkit provide concrete examples of workflows for orthopedic practices interested in incorporating decision aids into routine care.A bundle of implementation strategies, including a learning collaborative, external facilitation, and audit and feedback, helped most sites meet targets for decision aid implementation.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"272989X251405892"},"PeriodicalIF":3.1,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145821868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-14DOI: 10.1177/0272989X251395679
Stavroula A Chrysanthopoulou, Jianing Wang, Shayla Nolen, Anusha Rajapaksha W M Madushani, Sean M Murphy, Benjamin P Linas, Laura F White
In health or medical studies, participants can often experience the outcome(s) of interest multiple times during the observation period, creating recurrent event data. Depending on the primary research objective, advanced statistical methods are required to correctly analyze this special type of data. This tutorial discusses 4 general frameworks, appropriate for analyzing recurrent events data: 1) extended Cox, 2) parametric survival, 3) longitudinal, and 4) multistate models. We present in detail the implementation of these methods, including a description of the required dataset structure, R code, and interpretation of results, using data from the CTN-0051 study, a randomized clinical trial comparing the effectiveness of opioid use disorder treatments. The objectives of 3 use case scenarios exemplify the usage and relevance of the methods for the analysis of recurrent events: 1) estimate adjusted effects, 2) make individual-level predictions, and 3) model a complicated process involving multidirectional transitions between disease states. We compare the methods, comment on their strengths and limitations, and make recommendations on the preferred method depending on the primary research objective.HighlightsRecurrent events are a common phenomenon in experimental research settings, and their analysis requires advanced survival modeling approaches. This tutorial aims to explain and make these approaches more accessible with code and detailed instructions.We compare a detailed list of statistical methods for analyzing recurrent events and make suggestions on which one should be used depending on the study objective.This tutorial will enable researchers to make better use of recurrent events data.
{"title":"Modeling Recurrent Events: A Tutorial Based on Relapse and Remitting Episodes during Medication-Assisted Treatment for Opioid Use Disorder.","authors":"Stavroula A Chrysanthopoulou, Jianing Wang, Shayla Nolen, Anusha Rajapaksha W M Madushani, Sean M Murphy, Benjamin P Linas, Laura F White","doi":"10.1177/0272989X251395679","DOIUrl":"10.1177/0272989X251395679","url":null,"abstract":"<p><p>In health or medical studies, participants can often experience the outcome(s) of interest multiple times during the observation period, creating recurrent event data. Depending on the primary research objective, advanced statistical methods are required to correctly analyze this special type of data. This tutorial discusses 4 general frameworks, appropriate for analyzing recurrent events data: 1) extended Cox, 2) parametric survival, 3) longitudinal, and 4) multistate models. We present in detail the implementation of these methods, including a description of the required dataset structure, R code, and interpretation of results, using data from the CTN-0051 study, a randomized clinical trial comparing the effectiveness of opioid use disorder treatments. The objectives of 3 use case scenarios exemplify the usage and relevance of the methods for the analysis of recurrent events: 1) estimate adjusted effects, 2) make individual-level predictions, and 3) model a complicated process involving multidirectional transitions between disease states. We compare the methods, comment on their strengths and limitations, and make recommendations on the preferred method depending on the primary research objective.HighlightsRecurrent events are a common phenomenon in experimental research settings, and their analysis requires advanced survival modeling approaches. This tutorial aims to explain and make these approaches more accessible with code and detailed instructions.We compare a detailed list of statistical methods for analyzing recurrent events and make suggestions on which one should be used depending on the study objective.This tutorial will enable researchers to make better use of recurrent events data.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"272989X251395679"},"PeriodicalIF":3.1,"publicationDate":"2025-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12707579/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145757760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-11DOI: 10.1177/0272989X251391177
Liam Strand, Erik Gustavsson, Gustav Tinghög
BackgroundResource scarcity during large-scale crises, such as pandemics, can increase the emphasis on efficiency in medical decision making. However, it remains unclear whether such shifts are primarily driven by the direct experience of scarcity or by the way in which ethical principles for health care priority setting are expressed in the context of a crisis. This study investigates whether a national crisis affects public support for health care priority-setting principles and whether abstract versus concrete formulations of these principles shape that support.DesignWe conducted a preregistered online experiment (N = 1,404) to examine public attitudes toward three ethical principles formalized in the Swedish ethical platform-human dignity, needs-solidarity, and cost-effectiveness-in both crisis and noncrisis contexts. We also manipulated how the principles were presented, using either abstract or concrete formulations.ResultsIn the crisis condition, support for the human dignity and cost-effectiveness principles decreased, while support for the needs-solidarity principle increased. However, these effects were small, and the overall ranking of the principles remained stable. Notably, the level of abstractness had a stronger impact than the crisis context did: support for needs solidarity was higher when described abstractly, whereas support for cost-effectiveness increased when it was presented in a more concrete, action-oriented way. Support for the human dignity principle was unaffected by the abstractness manipulation.ConclusionThe findings suggest that people's moral views are relatively stable in the face of crisis. Rather than the crisis context itself, the way ethical principles are formulated-abstractly or concretely-may be a more powerful driver of shifts in public support for different moral values in health care priority setting.HighlightsPublic support for ethical principles remained largely stable during a simulated national crisis.The level of abstraction in how principles were presented strongly influenced support.Support for needs-solidarity increased in a crisis, while cost-effectiveness support declined.The way ethical principles were formulated had a greater impact than the presence of a crisis.
{"title":"Do Moral Views Change during a Crisis? An Experiment on Health Care Priority Setting.","authors":"Liam Strand, Erik Gustavsson, Gustav Tinghög","doi":"10.1177/0272989X251391177","DOIUrl":"https://doi.org/10.1177/0272989X251391177","url":null,"abstract":"<p><p>BackgroundResource scarcity during large-scale crises, such as pandemics, can increase the emphasis on efficiency in medical decision making. However, it remains unclear whether such shifts are primarily driven by the direct experience of scarcity or by the way in which ethical principles for health care priority setting are expressed in the context of a crisis. This study investigates whether a national crisis affects public support for health care priority-setting principles and whether abstract versus concrete formulations of these principles shape that support.DesignWe conducted a preregistered online experiment (<i>N</i> = 1,404) to examine public attitudes toward three ethical principles formalized in the Swedish ethical platform-human dignity, needs-solidarity, and cost-effectiveness-in both crisis and noncrisis contexts. We also manipulated how the principles were presented, using either abstract or concrete formulations.ResultsIn the crisis condition, support for the human dignity and cost-effectiveness principles decreased, while support for the needs-solidarity principle increased. However, these effects were small, and the overall ranking of the principles remained stable. Notably, the level of abstractness had a stronger impact than the crisis context did: support for needs solidarity was higher when described abstractly, whereas support for cost-effectiveness increased when it was presented in a more concrete, action-oriented way. Support for the human dignity principle was unaffected by the abstractness manipulation.ConclusionThe findings suggest that people's moral views are relatively stable in the face of crisis. Rather than the crisis context itself, the way ethical principles are formulated-abstractly or concretely-may be a more powerful driver of shifts in public support for different moral values in health care priority setting.HighlightsPublic support for ethical principles remained largely stable during a simulated national crisis.The level of abstraction in how principles were presented strongly influenced support.Support for needs-solidarity increased in a crisis, while cost-effectiveness support declined.The way ethical principles were formulated had a greater impact than the presence of a crisis.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"272989X251391177"},"PeriodicalIF":3.1,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145745348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-05DOI: 10.1177/0272989X251405237
{"title":"Corrigendum to \"Calculating the Expected Net Benefit of Sampling for Survival Data: A Tutorial and Case Study\".","authors":"","doi":"10.1177/0272989X251405237","DOIUrl":"https://doi.org/10.1177/0272989X251405237","url":null,"abstract":"","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"272989X251405237"},"PeriodicalIF":3.1,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145679197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1177/0272989X251395096
Divya Patil, Bengt Liljas, Peter J Neumann, Meng Li
<p><p>ObjectiveTo examine trends in the inclusion of societal costs in published cost-effectiveness analyses (CEAs), factors associated with their inclusion, and the impact of societal costs on incremental costs and incremental cost-effectiveness ratios (ICERs).MethodsWe analyzed 7,800 CEAs from 2013 to 2023 using the Tufts Medical Center CEA registry. The inclusion of societal costs in CEAs was evaluated across study characteristics. Associations between study characteristics and the inclusion of societal costs were analyzed using multivariate logistic regression. For studies reporting health care and societal perspectives, we assessed the impact of including societal costs on incremental costs and ICERs.ResultsFrom 2013 to 2023, CEAs including societal costs increased from 19% to 28%. Productivity was the most frequently reported component (12%), followed by transportation (8%), caregiver time (6%), patient time (5%), and consumption costs (1%). Compared with US-based analyses, studies from Scandinavian countries (adjusted odds ratio [OR]: 3.6) and the Netherlands (5.6) had higher odds of including societal costs, whereas studies from Canada (0.7), Australia (0.6), and the United Kingdom (0.4) had lower odds. Studies on mental health disorders (6.2) and immunization (4.1) had the highest odds of including societal costs. Compared with CEAs focused on adults, CEAs targeting pediatric populations had higher odds (OR: 1.6), while those targeting the elderly had lower odds (OR: 0.7). Upon inclusion of societal costs, incremental costs decreased in 72% and increased in 28% of studies; the ICER decreased in 74% and increased in 26% of studies.ConclusionDespite the increase in recent years, societal costs are infrequently included in CEAs, with substantial variation by country, disease, and population. Including societal costs can meaningfully improve value assessments and should be guided by relevance, evidence, and decision context.HighlightsBuilding on prior work by Kim et al. (2020), which analyzed approximately 6,900 cost-effectiveness analyses (CEAs), this study examined a larger and more recent sample of 7,800 CEAs from 2013 to 2023. In addition to updating the evidence base, we conducted new analyses to assess trends, associated factors, and the effect of including societal costs on incremental cost-effectiveness ratios (ICERs), thus providing insights that were not explored in prior work and addressing a key evidence gap in health economics.The inclusion of societal costs in CEAs rose modestly from 19% to 28% from 2013 to 2023, with substantial variation across countries, diseases, and intervention types. In some cases, the inclusion of societal costs affected incremental costs and ICERs enough to cross commonly used cost-effectiveness thresholds.The inclusion of societal costs can help improve value assessments in health care interventions, but it should be guided by relevance, available evidence, and the potential to influence decision maki
{"title":"When Do Published Cost-Effectiveness Analyses Include Societal Costs? An Empirical Analysis, 2013-2023.","authors":"Divya Patil, Bengt Liljas, Peter J Neumann, Meng Li","doi":"10.1177/0272989X251395096","DOIUrl":"https://doi.org/10.1177/0272989X251395096","url":null,"abstract":"<p><p>ObjectiveTo examine trends in the inclusion of societal costs in published cost-effectiveness analyses (CEAs), factors associated with their inclusion, and the impact of societal costs on incremental costs and incremental cost-effectiveness ratios (ICERs).MethodsWe analyzed 7,800 CEAs from 2013 to 2023 using the Tufts Medical Center CEA registry. The inclusion of societal costs in CEAs was evaluated across study characteristics. Associations between study characteristics and the inclusion of societal costs were analyzed using multivariate logistic regression. For studies reporting health care and societal perspectives, we assessed the impact of including societal costs on incremental costs and ICERs.ResultsFrom 2013 to 2023, CEAs including societal costs increased from 19% to 28%. Productivity was the most frequently reported component (12%), followed by transportation (8%), caregiver time (6%), patient time (5%), and consumption costs (1%). Compared with US-based analyses, studies from Scandinavian countries (adjusted odds ratio [OR]: 3.6) and the Netherlands (5.6) had higher odds of including societal costs, whereas studies from Canada (0.7), Australia (0.6), and the United Kingdom (0.4) had lower odds. Studies on mental health disorders (6.2) and immunization (4.1) had the highest odds of including societal costs. Compared with CEAs focused on adults, CEAs targeting pediatric populations had higher odds (OR: 1.6), while those targeting the elderly had lower odds (OR: 0.7). Upon inclusion of societal costs, incremental costs decreased in 72% and increased in 28% of studies; the ICER decreased in 74% and increased in 26% of studies.ConclusionDespite the increase in recent years, societal costs are infrequently included in CEAs, with substantial variation by country, disease, and population. Including societal costs can meaningfully improve value assessments and should be guided by relevance, evidence, and decision context.HighlightsBuilding on prior work by Kim et al. (2020), which analyzed approximately 6,900 cost-effectiveness analyses (CEAs), this study examined a larger and more recent sample of 7,800 CEAs from 2013 to 2023. In addition to updating the evidence base, we conducted new analyses to assess trends, associated factors, and the effect of including societal costs on incremental cost-effectiveness ratios (ICERs), thus providing insights that were not explored in prior work and addressing a key evidence gap in health economics.The inclusion of societal costs in CEAs rose modestly from 19% to 28% from 2013 to 2023, with substantial variation across countries, diseases, and intervention types. In some cases, the inclusion of societal costs affected incremental costs and ICERs enough to cross commonly used cost-effectiveness thresholds.The inclusion of societal costs can help improve value assessments in health care interventions, but it should be guided by relevance, available evidence, and the potential to influence decision maki","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"272989X251395096"},"PeriodicalIF":3.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145649899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}